辽宁沈抚示范区下线首台心脏冷冻消融系统

Core Insights - The heart cryoablation system developed by Shenyang Pengyue Technology Co., Ltd. has been launched, marking a significant advancement in the integration of technological and industrial innovation in Liaoning Province [1][5] - This system addresses the global health challenge of atrial fibrillation, particularly persistent and long-term cases that typically require complex surgical interventions [1] - The innovative medical device has received approval from the National Medical Products Administration, filling a gap in the high-end medical equipment sector in China and providing new treatment pathways for patients with persistent atrial fibrillation [5] Group 1 - The heart cryoablation system is a benchmark achievement in cultivating the "low-temperature cryomedicine" industry chain in Liaoning Province [1] - The system utilizes core technologies such as "rapid cooling," "active rewarming," and "backside temperature feedback," featuring a dual gas circulation system with argon as the coolant and helium as the heat medium [1] - The development of this system involved collaboration between the founding team of Shenyang Pengyue Technology and Professor Wang Huishan's team from the Northern Theater Command General Hospital of the People's Liberation Army [1] Group 2 - The innovative medical device is specifically approved for the treatment of persistent atrial fibrillation in adult heart disease patients [5] - The system's unique features include active rewarming, vacuum insulation, and backside temperature feedback, which are pioneering technologies in the field [5] - The approval of this device represents a significant milestone in the domestic high-end medical equipment landscape, offering new diagnostic and treatment options for patients [5]